openPR Logo
Press release

FDA Device Chief Calls for Stricter Guidelines Amid Transvaginal Mesh Lawsuits

05-08-2012 05:19 PM CET | Politics, Law & Society

Press release from: The Byrd Law Firm

FDA Device Chief Calls for Stricter Guidelines Amid

The Byrd Law Firm commends FDA Device Chief Jeffrey Shuren's position on dangerous products including a surgical device that has led to countless transvaginal mesh lawsuits. Shuren has called for stricter guidelines, including closing a loophole related to products voluntarily recalled by manufacturers due to safety flaws.

Under the current laws, when a new medical device cites a current predicate, the FDA must approve the device unless there is an older version of it that the FDA or a court order removed from the market for safety reasons. Unfortunately, when a dangerous product is voluntarily recalled, the recall does not impact the further approval of the product and the FDA, by law, has to approve a product with a valid predicate despite the fact that the product was voluntarily recalled in the past.

Shuren has indicated that an average of 28 devices each year cite a predicate and are cleared for approval, despite the previous voluntary recalls. Transvaginal mesh devices were among those submitted and approved. Unfortunately, the products were still not safe when submitted for approval and countless women began experiencing side effects, many of which required multiple surgeries to correct.

Jason Byrd and the Byrd Law Firm have represented many women who have experienced side effects in transvaginal mesh lawsuits. Mr. Byrd commends Shuren saying, "It's time someone took action. The FDA is supposed to stop drug companies and medical device manufacturers from putting out dangerous products. Loopholes that allow bad products to be used on patients can cause significant unnecessary pain and suffering."

For details on the tranvsaginal mesh lawsuits brought by the Byrd Law Firm or more information on Jason Byrd's legal work protecting injured victims, visit his site at http://www.txbyrd.com or all 1.888.616.2973.

About Jason Byrd

Jason Byrd defended corporate clients and insurance companies before starting the Byrd Law Firm in 2005. Today, Jason Byrd specializes in defective medical devices, bad drugs and other personal injury cases and represents the interests of plaintiffs. For more information, read about him at www.txbyrd.com.

Jason M. Byrd
The Byrd Law Firm
448 Orleans, Beaumont, TX 77701
409-924-0660
http://www.txbyrd.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release FDA Device Chief Calls for Stricter Guidelines Amid Transvaginal Mesh Lawsuits here

News-ID: 220285 • Views:

More Releases from The Byrd Law Firm

Houston Personal Injury Lawyer Warns Teens of the Consequences of Dangerous Driv …
Houston personal injury lawyer Jason Byrd wants to remind teen drivers and their parents that the actions teenagers take behind the wheel can have lifelong consequences. These consequences not only include an accident, but also legal ramifications. Jason Byrd is releasing this warning after a story out of Rhode Island made national headlines when a 17-year-old had his driver's license revoked for life. The teen was driving with three passengers while
Byrd Law Comments on Whether Driver's Licenses for Undocumented Immigrants Reduc …
With many hit and run accidents caused by those without a driver's license, Beaumont personal injury attorney Jason Byrd wishes to discuss proposals to offer driver's licenses to undocumented immigrants. Such a proposal is currently under discussion in Los Angeles because it is believed that allowing undocumented immigrants to get a license would be safer. Those who currently do not have a license may be driving even without having undergone driver's
Brain Injury Attorney, Jason Byrd, Warns Those Hitting the Slopes this Winter
Jason Byrd, a brain injury attorney based out of Houston, TX, wants to caution those taking ski and snowboarding vacations in the coming months. He wishes to draw attention to the very real risk of brain injury on the slopes. “I think people have this misconception that since they’re dealing with snow, they don’t have to worry because their fall will be padded. But that simply is not true,” Jason

All 4 Releases


More Releases for FDA

FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility
Peyronie’s Disease Market - Only FDA approved product
The market is dominated by a single player, Endo International plc who sells the only FDA approved Peyronie’s disease product. In May 2015, the American Urological Association presented the first ever treatment guidelines for Peyronie’s disease recommending the use of Xiaflex. Furthermore, the company is creating awareness through its “Ask About the Curve” campaign. Also, reimbursement from the U.S. insurance providers will boost the demand for this product. The product
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30). Announcing New Design Control Training Courses Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation. GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet
11-09-2016 | Science & Education
GRCTS
FDA online training
Description: Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding